Noteworthy Tuesday Option Activity: HD, MRNA, ALB

Moderna (MRNA) experienced significant options trading volume, reaching 143% of its average daily trading volume, with notable activity in the $28.50 strike call option expiring May 2025. Similarly, Albemarle Corp. (ALB) saw options volume at 57.2% of its average daily volume, driven by high interest in the $45 strike put option expiring June 2025, indicating potentially bearish sentiment.

Analysis

Moderna Inc. (MRNA) experienced a significant surge in options trading, with volume reaching 146,935 contracts, representing approximately 14.7 million underlying shares and 143% of its average daily share volume over the past month. This activity was notably concentrated in the $28.50 strike call options expiring May 23, 2025, which saw 17,141 contracts traded. This heightened call volume suggests increased investor speculation or hedging activity, potentially anticipating a substantial upward price movement for MRNA by that future date. Concurrently, Albemarle Corp. (ALB) also saw notable options activity, with 19,266 contracts traded, equivalent to 57.2% of its recent average daily share volume of 3.4 million shares. For ALB, the focus was on the $45 strike put option expiring June 27, 2025, where 13,678 contracts changed hands, indicating significant interest in downside protection or bearish bets on the stock's performance through mid-2025.

Key Decisions for Investors

• Investors should closely monitor MRNA for upcoming catalysts or news flow, as the significant volume in May 2025 $28.50 call options signals heightened market anticipation for potential price appreciation or strategic hedging.
• For Albemarle, the substantial activity in June 2025 $45 strike puts warrants a cautious stance; investors may consider reviewing existing positions for downside risk or evaluating hedging strategies, particularly if holding a long position.
• The contrasting open interest in MRNA calls versus ALB puts could reflect divergent sector-specific views (Biotech vs. Materials/Chemicals) or stock-specific factors that traders are positioning for, meriting further due diligence on underlying company fundamentals.